According to Hong Kong Stock Exchange documents, Tianchen Biopharmaceutical (Suzhou) Co., Ltd.-B has passed the Hong Kong Stock Exchange listing hearing.

2026-05-21

According to Hong Kong Stock Exchange documents, Tianchen Biopharmaceutical (Suzhou) Co., Ltd.-B has passed the Hong Kong Stock Exchange listing hearing.